These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


346 related items for PubMed ID: 18437851

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
    Siedek EM, Schmidt H, Sture GH, Raue R.
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N, Greenwood NM, Sutton D, Chalmers WS, Tarpey I.
    Vet Microbiol; 2008 Apr 01; 128(1-2):48-55. PubMed ID: 18006253
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the antigenic relationships among canine parvovirus type 2 variants.
    Cavalli A, Martella V, Desario C, Camero M, Bellacicco AL, De Palo P, Decaro N, Elia G, Buonavoglia C.
    Clin Vaccine Immunol; 2008 Mar 01; 15(3):534-9. PubMed ID: 18160619
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
    Wilson S, Illambas J, Siedek E, Stirling C, Thomas A, Plevová E, Sture G, Salt J.
    Vaccine; 2014 Sep 22; 32(42):5420-4. PubMed ID: 25148778
    [Abstract] [Full Text] [Related]

  • 8. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
    Buonavoglia C, Cavalli A, Tempesta M, Voight V, Buonavoglia D, Corrente M, Sagazio P.
    New Microbiol; 1995 Oct 22; 18(4):371-5. PubMed ID: 8590389
    [Abstract] [Full Text] [Related]

  • 9. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ, Schultz RD.
    Am J Vet Res; 1997 Apr 22; 58(4):360-3. PubMed ID: 9099379
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monitoring of canine parvovirus (CPV) strains detected in vaccinated puppies in Brazil.
    Castro TX, Costa EM, Leite JP, Labarthe NV, Cubel Garcia RC.
    Res Vet Sci; 2011 Apr 22; 90(2):336-40. PubMed ID: 20609453
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].
    Truyen U.
    Tierarztl Prax; 1994 Dec 22; 22(6):579-84. PubMed ID: 7716757
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a canine parvovirus strain isolated from an adult dog.
    Cavalli A, Bozzo G, Decaro N, Tinelli A, Aliberti A, Buonavoglia D.
    New Microbiol; 2001 Jul 22; 24(3):239-42. PubMed ID: 11497080
    [Abstract] [Full Text] [Related]

  • 17. Antibody levels and protection to canine parvovirus type 2.
    Elia G, Cavalli A, Cirone F, Lorusso E, Camero M, Buonavoglia D, Tempesta M.
    J Vet Med B Infect Dis Vet Public Health; 2005 Jul 22; 52(7-8):320-2. PubMed ID: 16316392
    [Abstract] [Full Text] [Related]

  • 18. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J, Guo HC, Wei YQ, Dong H, Han SC, Ao D, Sun DH, Wang HM, Cao SZ, Sun SQ.
    Appl Microbiol Biotechnol; 2014 Apr 22; 98(8):3529-38. PubMed ID: 24413974
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.